NATHANIEL WELLY: Open Payments
NPI 1881741726 · COTTONWOOD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 42 payments from 15 companies in 2025. Trend: 2023 $714 · 2024 $970 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $319 |
| Edwards Lifesciences Corporation | 3 | $158 |
| Amgen Inc. | 4 | $146 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| ABBVIE INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| PFIZER INC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Eisai Inc. | 1 | $24 |
Products named: AIRSUPRA, SAPIEN 3 Ultra RESILIA, EVENITY, TRELEGY ELLIPTA, QULIPTA, Kerendia, GEMTESA, Veozah.
Industry payments across AZ — which companies pay providers there.
